Linked Life Data

16550578

Source:http://linkedlifedata.com/resource/pubmed/id/16550578

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2006-3-27
pubmed:abstractText
In patients with unresectable lung cancer or pulmonary metastases, isolated lung perfusion (ILP) has been described as an alternative method to deliver high-dose chemotherapy to the lungs, thereby minimizing systemic toxicity. Pharmacokinetics of ILP have not been extensively investigated. Therefore, we studied the feasibility of ILP with melphalan in a pig model with emphasis on pharmacokinetics and acute lung damage.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0022-4790
pubmed:author
pubmed:copyrightInfo
(c) 2006 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
93
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
410-6
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Isolated lung perfusion with melphalan: pharmacokinetics and toxicity in a pig model.
pubmed:affiliation
Department of Surgical Oncology and Cardiothoracic Surgery, VU University Medical Center, Amsterdam, The Netherlands.
pubmed:publicationType
Journal Article, Evaluation Studies